Skip to the card

2026-10-18 issue

Observed arrival · 2026-10-18

Wellchosen Health's cash-pay care tracker

wellchosenhealth.com Visit website
Editorial interest 84/100 Selection signal · not a rating of the site

A US guide compares cash prices for GLP-1s, hormone therapy and other self-pay care, alongside reviews of providers and regulatory records.

Landing page captured for the 2026-10-18 issue.
For
US patients comparing self-pay care options
Worth noticing
Its stated review rule flags live FDA-cited claims, a BBB rating of D or F, patterned billing complaints, or regulator action as Avoid—and says it will not link those providers.

Field notes

The page breaks out categories including GLP-1 brands and doses, menopause therapy, TRT, concierge medicine, direct primary care, longevity testing and wellness injections. It says listed prices come from seller or drugmaker pages, with dates and exclusions noted; examples include $50–$100 monthly for direct primary care and $2,250–$2,930 annual MDVIP fees. Its stated review system separates providers into Clean, Use caution, Avoid and Not yet rated.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Scannable Architecture

359,926 arrived 1,000 judged 988 catalogued Enter the complete issue
wellchosenhealth.com

Landing page observed 2026-10-18. The live site may have changed.